| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,475 |
2,601 |
$382K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,700 |
2,611 |
$306K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,226 |
652 |
$120K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
783 |
633 |
$57K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
736 |
589 |
$47K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,665 |
1,292 |
$34K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
657 |
150 |
$28K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
933 |
514 |
$20K |
| 80053 |
Comprehensive metabolic panel |
3,884 |
2,747 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
257 |
160 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,420 |
2,892 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
435 |
172 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
210 |
192 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,017 |
868 |
$9K |
| 80061 |
Lipid panel |
815 |
727 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
72 |
40 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
148 |
82 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
96 |
67 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
50 |
36 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
616 |
552 |
$5K |
| 87631 |
|
36 |
32 |
$3K |
| 83735 |
|
1,157 |
761 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
114 |
91 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
45 |
28 |
$2K |
| 81001 |
|
1,122 |
810 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
5,192 |
3,584 |
$1K |
| 84484 |
|
437 |
202 |
$908.79 |
| 71045 |
Radiologic examination, chest; single view |
14 |
12 |
$833.96 |
| 87276 |
|
91 |
73 |
$812.13 |
| 87275 |
|
91 |
73 |
$631.64 |
| J3490 |
Unclassified drugs |
562 |
185 |
$619.76 |
| 84439 |
|
85 |
74 |
$547.97 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20 |
12 |
$345.05 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$255.51 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
60 |
41 |
$214.72 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
34 |
25 |
$129.35 |
| 82044 |
|
31 |
27 |
$118.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
64 |
45 |
$112.86 |
| 83605 |
|
26 |
12 |
$81.92 |
| 83690 |
|
15 |
12 |
$56.24 |
| 86140 |
|
16 |
14 |
$44.49 |
| 85610 |
|
21 |
12 |
$19.83 |